Deals Rumor Mill: Johnson & Johnson, WGL Holdings, Avaya

By Benjamin Horney (November 29, 2016, 2:16 PM EST) -- Johnson & Johnson has increased its offer to take over Swiss biotech Actelion after having been initially rejected last week, Reuters reported on Tuesday. According to the report, the U.S. health care giant had launched a proposal valued at about 25.5 billion Swiss francs ($25.15 billion) but was rejected and has now upsized the offer. Exactly how high the price tag was raised was not disclosed. The companies confirmed last week that they had held talks about a potential transaction, although no deal is guaranteed....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!